Pharmaceutical-Grade Tea Catechins: EP 10.0 Compliance& CEP Documentation

2025-07-15 11:27

Article Title:  

Pharmaceutical-Grade Tea Catechins: EP 10.0 Compliance& CEP Documentation  

Detail Page Description:

EU-GMP certified tea catechins meeting EP 10.0 monographs.Full CEP documentation for drug master files. 98% polyphenol purity withendotoxin control.  


EDQM-Approved Catechins for PharmaceuticalApplications: Comprehensive EP 10.0 & CEP Compliance  

Blue Eyes Biotech Co., Ltd manufacturespharmacopeial-grade Camellia sinensis extract under EU GMP Annex 1 guidelines,delivering rigorously standardized tea catechins (>98% total polyphenols)that satisfy European Pharmacopoeia 10.0 monograph requirements for criticaldrug formulations.  


Regulatory Excellence:  

- CEP Active: EDQM Certification ofSuitability (CEP No. XYZ123) covering chemical/biological profiles  

- EP 10.0 Conformity: Validated methods forcatechins quantification (HPLC-UV per 2.2.29)  

- ICH Q7 Compliance: Class D cleanroom isolationwith <ISO 5 particle control  


Critical Quality Attributes:  

- Endotoxin Control: <0.25 EU/mg (LALtest per EP 2.6.14) for injectableapplications  

- Elemental Impurities: Meets ICH Q3DOption 1 limits (As<1.5ppm, Cd<0.5ppm)

- Polymorphic Stability: XRD-confirmedamorphous structure preventing crystallization

- Residual Solvents: Class 2/3 solventsundetectable (GC-MS <10ppm)  


Application-Specific Validation:  

▶️ Cardiovascular Drugs:  

- Batch consistency in dissolution profiles(f2>85 per FDA SUPAC-IR)  

- Oxidation stability under acceleratedconditions (40°C/75% RH)  


▶️ Oncology Adjuvants:  

- Sterile filtration validation (0.22μmPVDF membrane compatibility)  

- Radiolytic sterilization compatibilitydata  


▶️ Nutraceutical Excipients:  

- TSE/BSE risk-free documentation (EC999/2001 compliant)  

- Allergen-free manufacturing  


Documentation Suite Includes:  

- CEP Dossier Modules 3.2.S &3.2.P  

- Process Validation Protocols (PPQ Lot: BEB-2024-CTP)

- Extractables/Leachables study forparenteral packaging  

- 36-month ICH Q1A(R2) stabilitycommitment  


Procurement Advantage:  

- Audit-ready EDQM/GMP documentation  

- Small-batch production (MOQ 5kg forclinical trials)  

- Cold-chain global logistics with QPdeclaration  


Download EP 10.0 Gap Analysis:www.blueeyes-bio.com

Request CEP Draft Review:[email protected]  

Name:
Message:
Verification code:
Submit
Comment